Product Classification
Classified as a musculoskeletal tissue repair research combination
Description
The BPC-157 + TB-500 combination is explored for synergistic effects on tissue repair, angiogenesis,and cell migration.
BPC-157 is derived from Body Protection Compound, while TB-500 is a fragment of Thymosin Beta-4 involved in actin regulation.
Specifications
- Molecular Type: Combined peptide regimen
- Mechanisms: Angiogenesis, fibroblast migration, cytoskeletal support, ECM modulation
Research Notes
- Tissue Repair: animal models suggest enhanced wound and musculoskeletal healing.
- Angiogenesis: both peptides associated with vascular growth and endothelial cell support.
- Fibroblast Migration: TB-500 implicated in cytoskeletal and actin pathways; BPC-157 in fibroblast
recruitment. - Musculoskeletal Use-Cases: preclinical interest in tendon, ligament, and muscle injury models.
Regulatory StatementFor research use only. Not for human or animal consumption.
Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease.
Reviews
There are no reviews yet.